Showing results 1 to 2 of 2
Issue Date | Title | Journal Title |
---|---|---|
2015 | Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma | MOLECULAR CANCER THERAPEUTICS |
2015 | Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma | ONCOTARGET |